Pharma BD Deal Intelligence
Merck & Co. Inc. / Organon & Co.
2007 · Acquisition/Merger · $14.4B · Complete
Outcome Score
48
Mixed — partial payoff, real shortfalls.
Write a proper summary of the 2007 ~$14.4B all-cash acquisition of Organon BioSciences N.V. from Akzo Nobel (with the buyer-attribution caveat below).
Key facts
- Announced Nov 01, 2007
- Closed Nov 01, 2007
- Deal value $14.4B
- Deal type Acquisition/Merger
- Therapeutic area Cardiovascular, Dermatology, Immunology, Metabolic, Neurology, Oncology, Respiratory, Women's Health
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals